Exhibit 99.3
WEBMD HEALTH CORP.
2007 FINANCIAL GUIDANCE SUMMARY
(in millions, except per share amounts)
2007 FINANCIAL GUIDANCE SUMMARY
(in millions, except per share amounts)
Quarter Ended | Year Ended | |||||||||||||||||||
Nine Months Ended | December 31, 2007 | December 31, 2007 | ||||||||||||||||||
September 30, 2007 | Range | Range | ||||||||||||||||||
Revenue | $ | 238.6 | $ | 94.0 | $ | 98.0 | $ | 332.6 | $ | 336.6 | ||||||||||
Earnings before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”) (a) | 51.8 | 30.0 | 32.5 | 81.8 | 84.3 | |||||||||||||||
Adjusted EBITDA per diluted common share | $ | 0.87 | $ | 0.50 | $ | 0.54 | $ | 1.36 | $ | 1.41 | ||||||||||
Interest, taxes, depreciation, amortization and other non-cash items (b) | ||||||||||||||||||||
Interest income | 8.5 | 3.4 | 3.5 | 11.9 | 12.0 | |||||||||||||||
Depreciation and amortization | (20.0 | ) | (7.3 | ) | (7.1 | ) | (27.3 | ) | (27.1 | ) | ||||||||||
Non-cash advertising | (2.5 | ) | (3.2 | ) | (3.0 | ) | (5.7 | ) | (5.5 | ) | ||||||||||
Non-cash stock-based compensation | (15.6 | ) | (4.2 | ) | (4.1 | ) | (19.8 | ) | (19.7 | ) | ||||||||||
Income tax provision (c) | (4.7 | ) | (3.4 | ) | (3.8 | ) | (8.1 | ) | (8.5 | ) | ||||||||||
Net income | $ | 17.6 | $ | 15.3 | $ | 18.0 | $ | 32.8 | $ | 35.5 | ||||||||||
Net income per common share: | ||||||||||||||||||||
Basic | $ | 0.31 | $ | 0.27 | $ | 0.32 | $ | 0.57 | $ | 0.62 | ||||||||||
Diluted | $ | 0.29 | $ | 0.26 | $ | 0.30 | $ | 0.55 | $ | 0.59 | ||||||||||
Weighted-average shares outstanding used in computing net income per common share: | ||||||||||||||||||||
Basic | 57.1 | 57.1 | 57.1 | 57.1 | 57.1 | |||||||||||||||
Diluted | 59.7 | 60.0 | 60.0 | 60.0 | 60.0 | |||||||||||||||
(a) | See Annex A — Explanation of Non-GAAP Financial Measures | |
(b) | Reconciliation of Adjusted EBITDA to net income | |
(c) | Our guidance for Q4 2007 does not contemplate any benefit stemming from the reversal of valuation allowance against our deferred tax assets |
FINANCIAL GUIDANCE SUMMARY
2008 Financial Guidance
(in millions, except per share amounts)
(in millions, except per share amounts)
Year Ended | ||||||||
December 31, 2008 | ||||||||
Range | ||||||||
Revenue | $ | 420.0 | $ | 435.0 | ||||
Earnings before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”) (a) | 120.0 | 130.0 | ||||||
Adjusted EBITDA per diluted common share | $ | 1.94 | $ | 2.10 | ||||
Interest, taxes, depreciation, amortization and other non-cash items (b) | ||||||||
Interest income | 14.0 | 15.0 | ||||||
Depreciation and amortization | (31.0 | ) | (29.0 | ) | ||||
Non-cash advertising | (5.0 | ) | (5.0 | ) | ||||
Non-cash stock-based compensation | (23.0 | ) | (22.0 | ) | ||||
Income tax provision (c) | (31.0 | ) | (36.0 | ) | ||||
Net income | $ | 44.0 | $ | 53.0 | ||||
Net income per common share: | ||||||||
Basic | $ | 0.75 | $ | 0.90 | ||||
Diluted | $ | 0.71 | $ | 0.85 | ||||
Weighted-average shares outstanding used in computing net income per common share: | ||||||||
Basic | 59.0 | 59.0 | ||||||
Diluted | 62.0 | 62.0 |
(a) | See Annex A — Explanation of Non-GAAP Financial Measures | |
(b) | Reconciliation of Adjusted EBITDA to net income | |
(c) | Our guidance for 2008 contemplates a non-cash federal tax provision, and does not contemplate any benefit stemming from the reversal of valuation allowance against our deferred tax assets |